Iodine 123-metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction

Clinical Physiology and Functional Imaging

Volumn 25, Issue 1, 2005, Pages 34-39

  Yuyama, Reisuke ^a   Yuasa, Fumio ^a   Hikosaka, Makoto ^a   Mimura, Jun ^a   Kawamura, Akihiro ^a   Hatada, Kengo ^a   Motohiro, Motohiro ^a   Iwasaki, Masayoshi ^a   Sugiura, Tetsuro ^b   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Iodine 123 metaiodobenzylguanidine imaging; Left venticular dysfunction; Microneurography; Muscle sympathetic nerve activity; Plasma norepinphrine

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; NORADRENALIN; TRACER;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART SCINTISCANNING; HEART VOLUME; HUMAN; IMAGE ANALYSIS; MALE; MEDIASTINUM; MUSCLE INNERVATION; NEUROGRAPHY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SUPINE POSITION; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 13544258989     PISSN: 14750961     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2004.00571.x     Document Type: Article

References (24)

1. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol (1999); 33: 1442-1452.
2. Cohn JN, Levine B, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J Med (1984); 311 819-823.
3. Davis D, Baily R, Zelis R. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol (1988); 254: E760-766.
4. Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand (1972); 84: 82-94.
5. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986); 57: 450-458.
6. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation (1994); 90: 248-253.
7. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Bo AD, Sala C, Bolla GB, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation (1995); 92: 3206-3211.
8. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nerve activity. Circulation (1986); 73: 615-621.
9. Hikosaka M, Yuasa F, Yuyama R, Mimura J, Kawamura A, Motohiro M, Iwasaki M, Sugiura T, Iwasaka T. Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. J Cardiovasc Pharmacol (2002); 40: 875-880.
10. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, Fukuyama T. Iodine-123 meta-iodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol (1995); 26 1594-1599.
11. Kaye DM, Lambert GW, Dewar EM, Jennings GL, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol (1994); 23: 570-578.
12. Kingwell BA, Thompson JM, Kaye DM, Mcpherson GA, Jenings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation (1994); 90: 234-240.
13. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwaltes WH. Myocardial imaging in man with Iodine-123 meta-iodobenzylguanidine. J Nucl Med (1981); 22: 129-132.
14. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res (1985); 57: 461-469.
15. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler M. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation (1993); 88: 136-145.
16. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med (1992); 33: 471-477.
17. Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, Hirata A, Asai M, Kusuoka H, Hori M, Hoki N. Prognostic significance of cardiac I-123 meta-iodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart (2001); 86: 656-660.
18. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J (1987); 114: 148-152.
19. Rundqvist B, Elam M, Eisenhofer G, Friberg P. Normalization of total body and regional sympathetic hyperactivity in heart failure after cardiac transplantation. J Heart Lung Transplant (1996); 15: 516-526.
20. Rundqvist B, Elam M, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation (1997); 95: 169-175.
21. Schofer J, Spielmann R, Schuchert A, Weber K, Schilder M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1988); 12: 1252-1258.
22. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, Glowniak JV, Sherman P, Beierwaltes WH. Meta-iodobenzylguanidine to map scintigarphically the adrenergic nervous system in man. J Nucl Med (1987); 28: 1625-1636.
23. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (1992); 453: 45-58.
24. Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, Asai M, Makino N, Kioka H, Kusuika H, Hori M, Hoki N. Comparison of the prognostic value of cardiac Iodine-123 meta-iodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure. J Am Coll Cardiol (2003); 41: 231-238.